Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Frontal, Striatal, and Medial Temporal Sensitivity to Value Distinguishes Risk-Taking from Risk-Aversive Older Adults during Decision Making.

Goh JO, Su YS, Tang YJ, McCarrey AC, Tereshchenko A, Elkins W, Resnick SM.

J Neurosci. 2016 Dec 7;36(49):12498-12509.

PMID:
27927964
2.
3.

Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine Dependence.

Okita K, Petersen N, Robertson CL, Dean AC, Mandelkern MA, London ED.

Neuropsychopharmacology. 2016 Nov;41(12):2913-2919. doi: 10.1038/npp.2016.105.

PMID:
27329684
4.

Risk Taking for Potential Reward Decreases across the Lifespan.

Rutledge RB, Smittenaar P, Zeidman P, Brown HR, Adams RA, Lindenberger U, Dayan P, Dolan RJ.

Curr Biol. 2016 Jun 20;26(12):1634-9. doi: 10.1016/j.cub.2016.05.017.

5.

Age-related changes in binding of the D2/3 receptor radioligand [(11)C](+)PHNO in healthy volunteers.

Matuskey D, Worhunksy P, Correa E, Pittman B, Gallezot JD, Nabulsi N, Ropchan J, Sreeram V, Gudepu R, Gaiser E, Cosgrove K, Ding YS, Potenza MN, Huang Y, Malison RT, Carson RE.

Neuroimage. 2016 Apr 15;130:241-7. doi: 10.1016/j.neuroimage.2016.02.002.

PMID:
26876475
6.

Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals.

Okita K, Ghahremani DG, Payer DE, Robertson CL, Mandelkern MA, London ED.

Int J Neuropsychopharmacol. 2016 Apr 29;19(5). pii: pyv129. doi: 10.1093/ijnp/pyv129.

7.

Mesenchymal stem cells-based therapy as a potential treatment in neurodegenerative disorders: is the escape from senescence an answer?

Castorina A, Szychlinska MA, Marzagalli R, Musumeci G.

Neural Regen Res. 2015 Jun;10(6):850-8. doi: 10.4103/1673-5374.158352. Review.

8.

Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study.

Nakajima S, Caravaggio F, Boileau I, Chung JK, Plitman E, Gerretsen P, Wilson AA, Houle S, Mamo DC, Graff-Guerrero A.

J Cereb Blood Flow Metab. 2015 Nov;35(11):1812-8. doi: 10.1038/jcbfm.2015.129.

9.

Molecular approaches for manipulating astrocytic signaling in vivo.

Xie AX, Petravicz J, McCarthy KD.

Front Cell Neurosci. 2015 Apr 21;9:144. doi: 10.3389/fncel.2015.00144. Review.

10.

Neural correlates of positive and negative performance feedback in younger and older adults.

Drueke B, Weichert L, Forkmann T, Mainz V, Gauggel S, Boecker M.

Behav Brain Funct. 2015 Apr 16;11:17. doi: 10.1186/s12993-015-0062-z.

11.

Age moderates the effect of acute dopamine depletion on passive avoidance learning.

Kelm MK, Boettiger CA.

Pharmacol Biochem Behav. 2015 Apr;131:57-63. doi: 10.1016/j.pbb.2015.01.014.

12.

The effects of age on resting state functional connectivity of the basal ganglia from young to middle adulthood.

Manza P, Zhang S, Hu S, Chao HH, Leung HC, Li CS.

Neuroimage. 2015 Feb 15;107:311-22. doi: 10.1016/j.neuroimage.2014.12.016.

13.

Reduction of Continuous Theta Burst Stimulation-Induced Motor Plasticity in Healthy Elderly With COMT Val158Met Polymorphism.

Lee NJ, Ahn HJ, Jung KI, Ohn SH, Hong J, Kim YJ, Yoo WK.

Ann Rehabil Med. 2014 Oct;38(5):658-64. doi: 10.5535/arm.2014.38.5.658.

14.

New cellular and molecular approaches to ageing brain.

Tripathi A.

Ann Neurosci. 2012 Oct;19(4):177-82. doi: 10.5214/ans.0972.7531.190410. Review.

15.

The effects of aging on insight into illness in schizophrenia: a review.

Gerretsen P, Plitman E, Rajji TK, Graff-Guerrero A.

Int J Geriatr Psychiatry. 2014 Nov;29(11):1145-61. doi: 10.1002/gps.4154. Review.

16.

Catechol-O-methyltransferase Val158Met polymorphism on the relationship between white matter hyperintensity and cognition in healthy people.

Liu ME, Huang CC, Yang AC, Tu PC, Yeh HL, Hong CJ, Liou YJ, Chen JF, Chou KH, Lin CP, Tsai SJ.

PLoS One. 2014 Feb 13;9(2):e88749. doi: 10.1371/journal.pone.0088749.

17.

Recent molecular approaches to understanding astrocyte function in vivo.

Davila D, Thibault K, Fiacco TA, Agulhon C.

Front Cell Neurosci. 2013 Dec 24;7:272. doi: 10.3389/fncel.2013.00272. Review.

18.

Establishing test-retest reliability of an adapted [(18)F]fallypride imaging protocol in older people.

Dunn JT, Clark-Papasavas C, Marsden P, Baker S, Cleij M, Kapur S, Kessler R, Howard R, Reeves SJ.

J Cereb Blood Flow Metab. 2013 Jul;33(7):1098-103. doi: 10.1038/jcbfm.2013.55.

19.

Effects of PPP1R1B (DARPP-32) Polymorphism on Feedback-Related Brain Potentials Across the Life Span.

Hämmerer D, Biele G, Müller V, Thiele H, Nürnberg P, Heekeren HR, Li SC.

Front Psychol. 2013 Mar 4;4:89. doi: 10.3389/fpsyg.2013.00089.

20.

Vulnerable neural systems and the borderland of brain aging and neurodegeneration.

Jagust W.

Neuron. 2013 Jan 23;77(2):219-34. doi: 10.1016/j.neuron.2013.01.002. Review.

Items per page

Supplemental Content

Support Center